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NEBULIZED SYNTHETIC SURFACTANT IN REPERFUSION INJURY AFTER SINGLE LUNG 
TRANSPLANTATION 
Martin Str~ber, MD, Joachim Cremer, MD, Wolfgang Harringer, MD, Stephan W. Hirt, MD, 
Angelika Costard-Jfickle, MD, and Axel Haverich, MD, Kiel, Germany 
Reperfusion injury is one of the major causes of early 
morbidity and mortality after lung transplantation. Fea- 
tures of thi s syndrome are pulmonary edema, reduction of 
compliance, and impaired gas exchange, and these occur 
in about 20% of all lung transplant recipients. Usual 
treatment includes prolonged mechanical ventilation with 
elevated positive end-expiratory airway pressure (PEEP), 
enhanced mean airway pressure with high oxygen content 
(Fio2), and, in severe cases, inverse ratio ventilation and 
extracorporeal membrane oxygenation. We report on the 
successful treatment with nebulized synthetic surfactant 
(Exosurf; Wellcome, Burgwedel, Germany) of a patient in 
whom reperfusion injury developed 5 hours after right 
lung transplantation. 
Right lung transplantation was done in a 26-year-old 
woman who had sarcoidosis with terminal interstitial lung 
disease and recurrent failure of the right side of the heart. 
The patient had been dependent on continuous oxygen 
insufllation for 30 months before transplantation. Pulmo- 
nary hypertension was present with a mean pulmonary 
artery pressure of 50 mm Hg. 
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The surgical procedure was complicated by severe 
pleural adhesions. Extracorporeal circulation was re- 
quired to perform pneumonectomy of the right lung 
safely. In addition, an oversized donor lung prevented 
bilateral transplantation. 
During the first 5 postoperative hours signs of reperfu- 
sion injury occurred: Fio2 had to be increased from 35% 
to 60% to prevent hypoxia, the compliance dropped to 15 
ml/mm Hg, and edema of the transplanted lung was found 
clinically and on chest x-ray film 6 hours after transplan- 
tation. At this time mean pulmonary artery pressure was 
increased (32 mm Hg), the use of catecholamines was not 
required, and prostacyclin fusion at a rate of 20/xg/hour 
had already been started on the patient's arrival at the 
intensive care unit. Placement of the patient in the prone 
position for 3 hours did not improve the clinical situation. 
At this point, surfactant replacement was started with 
nebulized synthetic surfactant at a rate of 3 gm per hour 
with use of a commercially available nebulizer and me- 
chanical ventilator (Evita 2; Dr/iger, Ltibeck, Germany). 
The ventilator allows for measurement of dynamic om- 
pliance, mean airway pressure, and PEEP. 
After 30 minutes of surfactant therapy a remarkable 
increase of the compliance from 16 to 30 ml/mm Hg was 
found (Fig. 1). As a consequence, without a change in 
airway pressure, the tidal volume rose from 400 ml to 
700 ml. Surfactant therapy was continued for 24 hours. 
During the therapy with nebulized synthetic surfactant 
prostacyclin i fusion was continued at the same rate. The 
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Fig. 1. Increase of compliance and tidal volume during surfactant replacement therapy. 
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Fig. 2. Chest x-ray film 5 hours after right lung transplan- 
tation before surfactant replacement therapy, revealing 
edema of transplanted lung. 
Fig. 3. Chest x-ray film 18 hours after right lung transplan- 
tation after 12 hours of surfactant replacement therapy. 
patient was under complete sedation with fentany! and 
midazolam infusion. 
The compliance reached a plateau at 39 ml/mm Hg 
after 18 hours. PEEP was decreased from 10 to 5 mm Hg. 
The increase of tidal volume at 6 hours was caused by 
decreasing PEEP with maintainance of pressure-con- 
trolled ventilation (Fig. 1). After about 6 hours, Fio 2 was 
lowered from 60% to 35% with maintainance of an 
arterial oxygen tension of 100 to 120 mm Hg. The mean 
pulmonary artery pressure dropped by 12 mm Hg and 
the mean airway pressure was reduced by 5 mm Hg. 
The edematous infiltrate of the transplanted lung on 
chest x-ray film before surfactant therapy was remark- 
ably reduced on control x-ray film after 12 hours of 
therapy and was completely resolved after 24 hours (Figs. 
2 and 3). 
After 24 hours surfactant replacement was discontinued 
without any change in compliance and lung function. 
Because the clinical situation remained stable, sedation 
was discontinued 6 hours later. The patient was extubated 
after 48 hours without signs of pulmonary insufficiency. 
The clinical course continued to be uneventful, and the 
patient was dismissed home from the hospital on postop- 
erative day 17. 
Reperfusion injury after lung transplantation can usu-
ally be treated effectively with PEEP ventilation. In severe 
cases, however, pulmonary insufficiency necessitates the 
use of extracorporeal membrane oxygenation. The under- 
lying pathomechanisms arenot well known, but laboratory 
investigations support he theory of impaired surfactant 
synthesis of a lung caused by ischemic damage to type II 
pneumocytes before transplantation, a' 2 Because of these 
observations and the successful use of surfactant replace- 
ment therapy in neonatal respiratory distress syndrome, 
Novick and associates 3 speculated in 1991 about surfac- 
tant replacement as a "future tool of the lung transplant 
surgeon." In this case the remarkable increase in compli- 
ance from 16 to 30 ml/mm Hg after 30 minutes of 
surfactant therapy reversed a potentially life-threatening 
situation. This and the rapid improvement ofgas exchange 
and reversal of an interstitial infiltrate have been shown to 
be typical responses to surfactant replacement therapy in 
neonatal respiratory distress syndrome. Therefore, this 
case indicates strong evidence for the effectiveness of 
surfactant therapy. 
Nebulization proved to be a convenient method of 
application with use of a standard commercially available 
nebulizer. The software for the ventilator was altered to 
allow for continuous nebulization. A synthetic surfactant 
preparation was used because of the high stability of the 
compound when dispersed. 
This case encourages more laboratory and clinical 
investigations concerning a transient loss of surfactant 
synthesis after ischemia and the potential role of surfac- 
tant replacement therapy s a future tool of treatment in 
lung reperfusion injury. 
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